Gillis R A, Hernandez Y M, Erzouki H K, Raczkowski V F, Mandal A K, Kuhn F E, Dretchen K L
Department of Pharmacology, Georgetown University School of Medicine, Washington, DC 20007, USA.
Drug Alcohol Depend. 1995 Mar;37(3):217-30. doi: 10.1016/0376-8716(94)01087-2.
Currently, augmentation of sympathetic nervous system function produced by cocaine is thought to be due primarily to stimulation of sympathetic centers in the brain (central effect) and to inhibition of catecholamine uptake into postganglionic sympathetic nerve terminals (peripheral effect). In this review of our work, we present the following evidence that cocaine-induced changes in cardiovascular function, particularly those that peak within 1 to 5 min after an i.v. bolus injection of the drug, are due to a peripheral effect of the drug: (1) In both dogs and cats, cocaine potentiates the tachycardiac effect of neurally-released and injected norepinephrine (NE). The time course of action and dosage range of cocaine that produces potentiation follows that which increases blood pressure (BP), heart rate (HR), rate-pressure product and coronary vasoconstriction. (2) Cocaine given in i.v. doses that increase BP in decerebrate cats (0.25-1.0 mg/kg) has no significant effect on directly monitored spontaneous cardiac sympathetic nerve activity (SNA). In fact, higher doses of cocaine (2-4 mg/kg, i.v.) consistently inhibit preganglionic cardiac and splanchnic nerve activity. (3) Cocaine (0.1-1.0 mg) administered directly into the blood supply of the hindbrain via the vertebral artery produces no increase in BP, HR or SNA in cats; instead, decreases in BP and sympathetic activity occur. The same dose (1 mg), injected i.v., does not depress BP or SNA. In addition, cocaine injected into the forebrain via the carotid artery or into the cerebral ventricles (0.1-1.0 mg) has very little effect on BP. Our results indicate that there is no significant excitatory effect of cocaine on CNS sympathetic centers, and that the sympathomimetic effects of cocaine on the cardiovascular system are likely to be mediated at peripheral sites.
目前,可卡因引起的交感神经系统功能增强被认为主要是由于刺激大脑中的交感神经中枢(中枢效应)以及抑制节后交感神经末梢摄取儿茶酚胺(外周效应)。在对我们工作的这篇综述中,我们提供了以下证据表明可卡因引起的心血管功能变化,尤其是静脉推注该药物后1至5分钟内达到峰值的那些变化,是由于该药物的外周效应:(1)在狗和猫中,可卡因都会增强神经释放和注射的去甲肾上腺素(NE)的心动过速效应。产生增强作用的可卡因的作用时间进程和剂量范围与升高血压(BP)、心率(HR)、速率 - 压力乘积和冠状动脉收缩的情况一致。(2)以能使去大脑猫血压升高的静脉剂量(0.25 - 1.0 mg/kg)给予可卡因,对直接监测的自发性心脏交感神经活动(SNA)没有显著影响。事实上,更高剂量的可卡因(2 - 4 mg/kg,静脉注射)持续抑制节前心脏和内脏神经活动。(3)通过椎动脉直接将可卡因(0.1 - 1.0 mg)注入后脑的血液供应中,猫的血压、心率或SNA没有升高;相反,血压和交感神经活动下降。相同剂量(1 mg)静脉注射则不会降低血压或SNA。此外,通过颈动脉或脑室注射可卡因(0.1 - 1.0 mg)对血压影响很小。我们的结果表明,可卡因对中枢神经系统交感神经中枢没有显著的兴奋作用,并且可卡因对心血管系统的拟交感神经作用可能在外周部位介导。